← Back to all earnings calls

TScan Therapeutics, Inc. Q3 FY2022 Earnings Call

TScan Therapeutics, Inc. (TCRX)

Earnings Call FY2022 Q3 Call date: 2022-11-09 Concluded

Share

Quarter scorecard

Revenue

$3.36M

+39.4% YoY

Diluted EPS

$-0.67

Net income

$

Documents & deck